Stem Cell

In ESC, BMP/TGF-β signaling pathway plays a key role in maintaining pluripotency and self-renewal. It signals through Smad proteins, and the FGF signaling pathway, which activates the MAPK and Akt pathways. The Wnt signaling pathway also promotes pluripotency. OCT-4, SOX2, and NANOG are three main transcription factors that are expressed and activated by these pathways. Induced pluripotent stem cells (iPSC) are pluripotent cells that can be generated from differentiated cells with forced expression of specific reprogramming factors. Both ESC and iPSC can be induced to develop into distinct cell types that associated with three primary germ layers: ectoderm, mesoderm and endoderm. Signaling pathways that control the development of these cell lineages, including BMP/TGF-β, Notch, Wnt/β-catenin, Hedgehog and Hippo pathways, which regulate cell division, growth and differentiation. Defects in stem cell signaling are related to developmental disorders and cancer.
-   B4923 TA 01Summary: CK1ε, CK1δ,and p38α inhibitor B4923 TA 01Summary: CK1ε, CK1δ,and p38α inhibitor
-   B6110 IMR-1Summary: Notch pathway inhibitor B6110 IMR-1Summary: Notch pathway inhibitor
-   C4813 ML-243Summary: inhibitor of cancer stem cells C4813 ML-243Summary: inhibitor of cancer stem cells
-   B1237 LH846Summary: Casein kinases inhibitor B1237 LH846Summary: Casein kinases inhibitor
-   A4351 PluriSIn 1 (NSC 14613)Target: Stearoyl-CoA 9-desaturase (SCD-1)Summary: SCD1 inhibitor A4351 PluriSIn 1 (NSC 14613)Target: Stearoyl-CoA 9-desaturase (SCD-1)Summary: SCD1 inhibitor
-   A3429 GANT 58Summary: GLI antagonist,novel and potent A3429 GANT 58Summary: GLI antagonist,novel and potent
-   A3449 GSK3431 CitationTarget: EZH2Summary: EZH2 inhibitor,potent,selective and cell permeable A3449 GSK3431 CitationTarget: EZH2Summary: EZH2 inhibitor,potent,selective and cell permeable
-   A3512 IWP-22 CitationSummary: Wnt production inhibitor,PORCN inhibitor A3512 IWP-22 CitationSummary: Wnt production inhibitor,PORCN inhibitor
-   A3543 LDE225 DiphosphateTarget: SmoothenedSummary: Smo antagonist A3543 LDE225 DiphosphateTarget: SmoothenedSummary: Smo antagonist
-   A3570 LY2090314Target: GSK-3Summary: Potent GSK-3 inhibitor A3570 LY2090314Target: GSK-3Summary: Potent GSK-3 inhibitor
